In CLL, primary resistance to CDC is mediated also by the presence of soluble protective protein complement factor H (CFH) that prevents the formation and deposition of additional C3b and propagation of the complement cascade. This evidence concerns the gene C3 and B-cell chronic lymphocytic leukemia.